Breyanzi® (lisocabtagene maraleucel)
for Lymphoma

Breyanzi (lisocabtagene maraleucel) is a CAR T-cell therapy used to treat specific types of non-Hodgkin lymphoma, including large B-cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma, and relapsed/refractory mantle cell lymphoma. T cells collected from a patient's blood are modified to recognize and kill cancer cells, then reinfused as a one-time treatment, aiming for complete and lasting remission.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Lymphoma